New pancreatic cancer drug carries a $39,800 monthly list price: What to know - Yahoo Finance
The story
- New pancreatic cancer drug carries a $39,800 monthly list price: What to know Yahoo Finance
- FDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Disease WSJ
- F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer The New York Times
- U.S. approves breakthrough pancreatic cancer drug, heralding a new era for an intractable disease Scientific American
- Pancreatic cancer drug approved by FDA is "exceptional moment," Boston researcher says CBS News
Related Markets
All MarketsMarket data may be delayed. Not financial advice.
Powered by Gab AI
The Story At A Glance
Reading this article now — analysis appears below
💡 AI analysis provides alternative perspectives on current events